Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

ImmunoGen Inc (IMGN)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ImmunoGen's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
ImmunoGen historical data, for real-time data please try another search
31.230 0.000    0.00%
09/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 31.220 - 31.250
ImmunoGen 31.230 0.000 0.00%

IMGN Recent Sentiments

 
This page contains information on users’ sentiments for the ImmunoGen Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Mar 22, 2024 Miguel Arroyo López   31.230 Mar 25, 2024 @ 31.230 0.00%
Jan 30, 2024 José Martins   29.420 Feb 05, 2024 @ 29.265 -0.53%
Jan 22, 2024 José Martins   29.590 Jan 22, 2024 @ 29.545 -0.15%
Jan 10, 2024 loke wai hoong   29.772 Feb 02, 2024 @ 29.260 -1.72%
Jan 02, 2024 José Martins   29.540 Jan 08, 2024 @ 29.575 +0.12%
Jan 02, 2024 Эдуард Болдырь   29.570 Jan 02, 2024 @ 29.570 0.00%
Jan 02, 2024 Эдуард Болдырь   29.545 Jan 02, 2024 @ 29.545 0.00%
Dec 26, 2023 José Martins   29.875 Jan 01, 2024 @ 29.650 -0.75%
Dec 13, 2023 Grzegorz Pożarski   29.710 Dec 18, 2023 @ 29.470 -0.81%
Dec 11, 2023 Lambert Heijmann   29.475 Jan 05, 2024 @ 29.650 +0.59%
Nov 30, 2023 Эльхан Адиев   29.255 Dec 22, 2023 @ 29.700 +1.52%
Nov 30, 2023 Moonlight Smith   29.305 Dec 04, 2023 @ 29.210 -0.32%
Nov 30, 2023 Ashok Patel   29.295 Dec 22, 2023 @ 29.700 +1.38%
Nov 30, 2023 Manuel Rosales   29.320 Dec 22, 2023 @ 29.700 +1.30%
Nov 30, 2023 André Bulten   28.810 Dec 04, 2023 @ 29.210 +1.39%
Nov 28, 2023 Sébastien LE GOASCOZ   15.995 Dec 22, 2023 @ 29.700 +85.68%
Nov 13, 2023 Davide Vitrano   14.625 Nov 13, 2023 @ 14.625 0.00%
Nov 03, 2023 Кирилл Каманин   16.235 Nov 03, 2023 @ 16.235 0.00%
Nov 03, 2023 LORENZO DAGLIO   15.670 Nov 30, 2023 @ 16.060 +2.49%
Oct 30, 2023 Bogdan Bogdan   15.110 Nov 30, 2023 @ 16.060 +6.29%
Oct 27, 2023 Владимир Драволин   15.145 Nov 30, 2023 @ 16.060 +6.04%
Oct 20, 2023 david de neve   14.785 Nov 30, 2023 @ 16.060 +8.62%
Aug 28, 2023 Erich Chudy   15.280 Nov 30, 2023 @ 16.060 -5.10%
Aug 14, 2023 vijay valtati   14.265 Nov 30, 2023 @ 16.060 +12.58%
Jul 31, 2023 은진 박   17.155 Nov 30, 2023 @ 16.060 -6.38%
Jul 31, 2023   17.010 Nov 30, 2023 @ 16.060 -5.58%
Jul 24, 2023 Juan Guzman   18.155 Nov 30, 2023 @ 16.060 -11.54%
Jun 23, 2023 Jordi Tomas   19.920 Nov 30, 2023 @ 16.060 -19.38%
Jun 12, 2023 Massimo Caputo   17.980 Sep 01, 2023 @ 15.840 -11.90%
Jun 06, 2023 José Martins   15.005 Nov 30, 2023 @ 16.060 +7.03%
Jun 05, 2023 LeonardPersin   15.290 Nov 30, 2023 @ 16.060 +5.04%
May 22, 2023 Gale Lazarus   14.570 Nov 30, 2023 @ 16.060 +10.23%
May 19, 2023 Hassan Hassan   14.245 Nov 30, 2023 @ 16.060 +12.74%
May 15, 2023 Рокер Сагаев   13.592 Nov 30, 2023 @ 16.060 +18.16%
May 11, 2023 Вадим Башун   13.485 Nov 30, 2023 @ 16.060 +19.10%
May 11, 2023 Valerio Angioli   13.620 Nov 30, 2023 @ 16.060 -17.91%
May 10, 2023 robert revesz   13.785 Nov 30, 2023 @ 16.060 +16.50%
May 10, 2023 Despina Kld   13.620 May 10, 2023 @ 13.695 -0.55%
May 08, 2023 Shavkat Ochilov   13.460 Nov 30, 2023 @ 16.060 +19.32%
May 05, 2023 Andreas Schatz   13.590 Nov 30, 2023 @ 16.060 +18.18%
May 04, 2023 J Trieu   13.235 Nov 30, 2023 @ 16.060 +21.34%
May 04, 2023 AMARØK CS   13.255 Nov 30, 2023 @ 16.060 +21.16%
May 04, 2023 Igor Leu   13.370 May 09, 2023 @ 13.340 +0.22%
May 04, 2023 fabio mazzeo   13.540 Nov 30, 2023 @ 16.060 +18.61%
May 04, 2023 Adam Rosenblat   13.409 Nov 30, 2023 @ 16.060 +19.77%
May 04, 2023 Andrew Godereaux   13.180 Nov 30, 2023 @ 16.060 -21.85%
May 04, 2023 동윤 강   13.380 Nov 30, 2023 @ 16.060 +20.03%
May 04, 2023 Anuj Sharma   13.105 Nov 30, 2023 @ 16.060 +22.55%
May 04, 2023 Simón Gast   13.150 May 09, 2023 @ 13.340 +1.44%
May 04, 2023 Abel García   12.310 Nov 30, 2023 @ 16.060 +30.46%
More
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

IMGN Comments

Write your thoughts about ImmunoGen Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Gale Lazarus
Gale Lazarus May 22, 2023 12:10PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Great stock. Fantastic drug for Ovarian cancer
Reply
2 0
Report
Nhat Doan
Nhat Doan May 16, 2023 7:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Being Slaughted for Eagles Meat today 🥰👍
Reply
1 0
Report
Nhat Doan
Nhat Doan May 04, 2023 7:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$ImmunoGen(IMGN.US)$ SELL OFF AND SHORT NOW BEFORE HAILO OPEN 🤗🥰👌👍💰
Reply
2 1
Report
Mindaugas Mindaugas
Mindaugas Mindaugas May 04, 2023 7:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
guessing?
Reply
0 0
Report
AMARØK CS
AMARØK CS May 04, 2023 7:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
should I sell?
Reply
1 0
Report
Gale Lazarus
Gale Lazarus May 04, 2023 7:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buy
Reply
0 0
Report
Nhat Doan
Nhat Doan May 03, 2023 5:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$ImmunoGen(IMGN.US)$ $ 200M Offer to Sell; TOMORROW is Big Sell Off 😞😩👎
Reply
2 1
Report
Gary Schachtschneider
Gary Schachtschneider May 03, 2023 2:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
PRICE TARGET raised to $15 by Truist Securities
Reply
1 0
Report
Nhat Doan
Nhat Doan May 03, 2023 10:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$ImmunoGen(IMGN.US)$ IT MUST DROP BACK ABOUT $8 WITH IN 2 WEEKS, LONG BUYERS MUST CASH OUT FOR PROFIT & SHORT SELLERS BE PATIENT AND WAIT +💰💰💰💰💰
Reply
1 0
Report
Luka Tsirekidze
Luka Tsirekidze Mar 01, 2023 3:59PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
its bull time here this week
Reply
1 0
Report
robert revesz
robert revesz Feb 07, 2022 4:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hi, do you have any news / "feelings" how will this stock behave after the earnings report coming up?
Reply
0 1
Report
Joe Jordan
Joe Jordan Nov 30, 2021 10:15AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug TrialImmunoGen said mirvetuximab, its treatment for patients with platinum-resistant ovarian cancer, performed well in a pivotal SORAYA trial. Mirvetuximab had a confirmed objective response rate (ORR) of 32.4%, the drugmaker said, with a duration of response (DOR) of 5.9 months in the 106-person trial.
Reply
3 0
Report
robert revesz
robert revesz Nov 30, 2021 7:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hello, does anyone know what has happened? +40%???
Reply
1 0
Report
Thao Bui
Thao Bui Nov 30, 2021 7:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
take profit and waiting it down and buy more
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email